Print
A Deadly Cancer in Need of New Options
Pancreatic cancer is one of the most aggressive and lethal cancers in the world. It resists conventional treatments such as surgery, chemotherapy, and radiation, and its five-year survival rate remains below 10 percent.
Because the disease is often detected late and spreads quickly, the search for new therapeutic strategies has become urgent. Researchers are turning to natural compounds from medicinal plants as a source of potential breakthroughs—and now, a humble sugar substitute is showing surprising promise.
A team from Hiroshima University has discovered that fermented stevia leaf extract may selectively kill pancreatic cancer cells while sparing healthy tissue. This finding opens the door to a new way of thinking about stevia—not only as a zero-calorie sweetener, but as a possible weapon in the fight against one of the hardest cancers to treat.
From Sweetener to Cancer Fighter
Stevia, widely used as a natural sugar alternative, contains more than just sweetness. It is rich in plant compounds with antioxidant, anti-inflammatory, and even anticancer potential. Previous studies showed that purified stevia components could slow or kill certain cancer cells, but the whole-leaf extract typically had limited potency unless taken in very high doses.
The Hiroshima University team explored whether fermentation—a natural process that uses beneficial microbes—could unlock more of stevia’s medicinal power. They chose Lactobacillus plantarum SN13T, a probiotic bacterium found in traditional fermented foods like sauerkraut and kimchi. The goal was to see if this microbial partnership could transform stevia’s natural compounds into forms more effective at fighting cancer.
Fermentation Unleashes Bioactive Power
By fermenting stevia leaf extract for 72 hours at body temperature under low-oxygen conditions, the researchers produced what they called fermented stevia leaf extract (FSLE). Tests revealed that FSLE was significantly more effective at killing pancreatic cancer cells than the unfermented version.
Even more promising, FSLE caused minimal harm to healthy kidney cells, a critical advantage over conventional chemotherapy drugs like cisplatin, which can severely damage the kidneys—especially the one nearest the pancreas. This selectivity suggests FSLE might offer a safer therapeutic profile if future studies confirm its effects in animals and humans.
The Antioxidant Edge
The team also found that fermentation enhanced the extract’s antioxidant power. FSLE was better at neutralizing harmful free radicals and protecting healthy cells from oxidative stress, a factor linked to cancer progression. This antioxidant boost likely supports the extract’s cancer-fighting activity by reducing cellular damage and inflammation.
Slowing the Spread
Beyond killing cancer cells, FSLE proved effective at stopping them from multiplying and migrating. Laboratory assays showed it reduced the ability of pancreatic cancer cells to form colonies and blocked their movement in wound-healing tests—both key steps in preventing metastasis.
The Discovery of CAME
Chemical analysis revealed why FSLE worked so well. During fermentation, enzymes from Lactobacillus plantarum transformed chlorogenic acid—a natural compound in stevia—into a more potent molecule called chlorogenic acid methyl ester (CAME). While absent in the unfermented extract, CAME was present in FSLE at significant levels and demonstrated stronger cancer-killing activity than its parent compound.
CAME was found to arrest cancer cells in the G0/G1 phase of their growth cycle, preventing them from dividing. It also triggered apoptosis, the programmed cell death that cancer cells often evade. On the genetic level, CAME increased the activity of pro-death genes such as Bax, Bad, Caspase-3, Caspase-9, Cytochrome c, and E-cadherin, while dialing down Bcl-2, a gene that helps cancer cells survive.
Why Selectivity Matters
One of the most striking features of FSLE and CAME is their ability to spare healthy cells while targeting cancerous ones. This selectivity is rare among chemotherapy agents, which often harm normal tissues as they attack tumors. Pancreatic cancer’s proximity to vital organs like the kidneys makes this safety factor especially important.
The Probiotic Connection
The study also highlights the broader potential of probiotics in medicine. By using Lactobacillus plantarum to ferment stevia, the researchers not only enhanced its anticancer properties but also created a natural partnership between a medicinal plant and a beneficial bacterium. This microbial biotransformation could serve as a model for developing other plant-based therapies.
Coauthor Masanori Sugiyama, who has studied more than 1,200 bacterial strains from plants and foods, believes this approach could turn everyday herbs into potent medicinal agents. “Microbial transformation is an effective strategy for enhancing the pharmacological efficacy of natural extracts,” he said.
Expert Perspective on Stevia’s Potential
Though not involved in the research, Dr. Joseph Mercola, a board-certified family physician, noted that the study reinforces the idea that stevia offers benefits beyond sweetness. Unlike artificial sweeteners such as aspartame or sucralose, pure stevia extract has minimal impact on blood sugar or insulin and may even support long-term health.
Mercola cautioned that consumers should avoid stevia products blended with fillers like dextrose or maltodextrin, which can raise blood sugar. But he sees the new findings as another reason to appreciate stevia’s potential—especially in its pure form.
From Lab to Life
While the results are promising, the study was conducted entirely in vitro, meaning on cancer cells in laboratory dishes. The next step will be animal studies to see how FSLE behaves in a living body, where factors like metabolism, immune response, and organ interactions come into play. The researchers plan to test different doses in mice to evaluate safety and efficacy.
If future research confirms these findings, FSLE could eventually be developed into a natural adjunct or alternative to conventional treatments for pancreatic cancer. Its selective toxicity, antioxidant boost, and ability to block metastasis make it an attractive candidate for further investigation.
A Sweet Future for Cancer Research
The idea that a plant best known for sweetening coffee and tea could also help fight one of the deadliest cancers underscores the untapped potential of natural products. This study not only spotlights stevia but also shows how fermentation and probiotics can transform familiar plants into powerful medicinal tools.
For now, FSLE remains an experimental therapy, but its story is a compelling example of how traditional foods and modern science can come together to address urgent health challenges. In the case of pancreatic cancer—where effective options are scarce—this sweet leaf may hold a bitter truth for many types of tumors… their days could be numbered.
